| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.4 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |